Spatial OMICS Market: By Technology (Spatial transcriptomics, Spatial Genomics and Spatial proteomics); By Product type (Instruments, consumables, software and others), And Region - Global Analysis of Market Size, Share & Trends For 2021-2022 And Forecasts To 2032
Spatial OMICS Market is expected to surpass USD 69.10 billion by 2032 from USD 32.99 billion in 2021 at a CAGR of 11.4% in the coming years, i.e., 2022-32
Spatial omics refers to a series of technologies that enable the overlaying of -omics data on tissue images. Under the general term omics, there are numerous different kinds of omics studies. Proteomics, epigenomics, transcriptomics, genomics, metabolomics, and lipidomic are all parts of spatial omics. Spatial omics integrates molecular analysis with geographic data pertaining to a cell's position inside a tissue. Thus, this technology offers a potent tool for investigating crucial phenomena including tissue structure and cell control. The investigation of the tissue microenvironment and the biology of the tumour is made feasible by the spatial profiling-based approaches, and it is also possible to assess the tissue biomarkers. All neurological disorders and rare diseases have proliferated around the globe, thus, the domains of spatial omics have grown in importance.
The Spatial OMICS Market is expected to project a notable CAGR of 11.4% in 2032.
Spatial OMICS Market is expected to surpass USD 69.10 billion by 2032 from USD 32.99 billion in 2021 at a CAGR of 11.4% in the coming years, i.e., 2022-32. The government's increased investment in R&D and the demand for early diagnoses are anticipated to fuel market expansion. High uses as diagnostic tools, particularly in the field of oncology, are another component of the spatial OMICS market drivers. The market is expanding due to the rising incidence and prevalence of cancer. Additionally, the market growth is boosted by the extensive research and development conducted by commercial and public organizations.
The consumables segment is expected to grow with a higher CAGR during 2022-32
Spatial OMICS Market is categorized on the basis of Product Type into Instruments, consumables, software and others. In 2021, the consumables segment held the highest market due to its high utilisation rate and the introduction of novel items. The creation of the consumables is directly related to the introduction of new instruments. As a result, both the instruments and the consumables segments are driven by this. Instruments segment is also predicted to grow at a high rate, it is further divided into mode and type. As more sophisticated equipment is created with the most recent technologies, such as high resolution, high speed, and this technology, these complicated biological samples are being studied. Additionally, this is used in the creation of innovative drugs, biomarkers, diagnostics, and product discoveries.
The Spatial transcriptomics segment is expected to grow with a higher CAGR during 2022-32
Spatial OMICS Market is categorized on the basis of technology into Spatial transcriptomics, Spatial Genomics and Spatial proteomics. In 2021, the market was dominated by the category of spatial transcriptomics. The study of single cells' transcriptomes has been hastened by ongoing developments in sequencing technologies. Designing novel approaches for high-throughput genomic analysis while preserving the spatial information of the tissue under observation or the subcellular localization of examined DNA/RNA is being done in order to conduct a thorough study of multicellular organisms. The ability to investigate spatial information in biological study has improved thanks to the development of numerous in situ technologies. Due to the confluence of the structure and function-focused studies of histology and embryology, as well as the function-oriented fields of biochemistry and molecular genetics, spatially detailed molecular analysis of biological processes is now possible.
Extensive research and development along with increasing cases of cancer is driving growth
High applications as diagnostic tools, notably in oncology, are among the spatial OMICS market drivers. The market is expanding due to the rising incidence and prevalence of cancer. Additionally, the market growth is boosted by the extensive research and development conducted by commercial and public organisations. Spatial genomic sequencing has emerged as a result of quick developments in the sequencing of tissues, genes, and single cells. Quantitative information on gene expression and the visualisation of DNA and RNA mapping inside tissue slices are both provided by spatial OMICS techniques. It is projected that the development of revolutionary spatial OMICS technologies will open up attractive potential for the diagnostics and translational research industries.
Technological improvements and increase in genetic illness is expected to surge demand
The market for spatial genomics and transcriptomics is expanding as a result of increased adoption of technologies for use in a variety of fields, including cancer and stem cell research, tissue-specific gene expression studies, embryogenesis and in-vitro fertilisation, and non-coding RNA characterization, among others. Additionally, an increase in the prevalence of genetic illnesses, the use of spatial genomics and transcriptomics to identify disease and treatment markers, as well as a rise in consumer appetite for tailored treatments, all contribute to the market's expansion. Furthermore, the greater indulgence of cells and their nucleic acid content is crucial for establishing a connection between disease and genome architecture, piqueing translational research' interest in the global market.
Lack of experienced workers and complicated methodology is likely to hamper the Market Growth
The lack of experienced workers needed to handle devices and conduct research operations will provide substantial obstacles for the global industry for spatial omics. Additionally, because transcriptome analysis involves increasingly complicated methodologies, such as labor-intensive approaches for doing experiments and evaluating biological entities, the market's expansion during the study period may be hampered.
(Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis)
Spatial OMICS Market is segmented based on regional analysis into five major regions: North America, Latin America, Europe, Asia Pacific and the Middle East and Africa. In 2021, North America had the largest share in the market of spatial OMICS. This is explained by the rising incidence of cancer, the rise in demand for individualized medication, the advancement of healthcare infrastructure, and the accessibility of cutting-edge diagnostic methods. The need for creating novel medicines has increased as a result of the rising rates of morbidity and mortality caused by cancer and other metabolic, autoimmune, and inflammatory disorders, which is what is driving this industry. Additionally, North American-based businesses are introducing fresh projects and initiatives aimed at expanding translational applications, which is fueling the market's expansion.
2020 saw a drop in the global market for spatial genomics and transcriptomics as a result of the COVID-19-led world recession. Many market participants' operations and financial performance have suffered as a result of the epidemic and slowing worldwide research initiatives. The sales of consumables and reagents needed for spatial genomics & transcriptomics analysis have decreased as a result of university & research institute closures. A rise in the use of spatial genomics and transcriptomics to analyse COVID-19 tissue autopsy, as well as a rise in the identification of biomarkers and their application in drug discovery and development programmer, will cause the market to rebound in 2021.
Market Size Value in 2021
USD 32.99 billion
Revenue Forecast in 2032
USD 69.10 billion
CAGR of 11.4% from 2022 to 2032
Base Year for Estimation
Revenue in USD billion and CAGR from 2022 to 2032
Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Product Type, Technology and Region
North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA)
Key Companies Profiled
Natera Inc., Dovetail Genomics, LLC, Fluidigm Corporation, Lunaphore Technologies SA, Vizgen Corporation, S2 Genomic, Rarecyte, Inc., Seven Bridges Genomics, Ultivue, Inc. and Other Prominent Players
The Spatial OMICS Market size was estimated at USD 32.99 billion in 2021 and is expected to reach USD 69.10 billion in 2032.
Spatial omics refers to a series of technologies that enable the overlaying of -omics data on tissue images. Under the general term omics, there are numerous different kinds of omics studies. Proteomics, epigenomics, transcriptomics, genomics, metabolomics, and lipidomic are all parts of spatial omics
The consumables and Spatial transcriptomics segments accounted for the larger share of the Spatial OMICS Market.
Key players in the Spatial OMICS Market are Natera Inc., Dovetail Genomics, LLC, Fluidigm Corporation, Lunaphore Technologies SA, Vizgen Corporation, S2 Genomic, Rarecyte, Inc., Seven Bridges Genomics, Ultivue, Inc. and Other Prominent Players.
The government's increased investment in R&D and the demand for early diagnoses are anticipated to fuel market expansion.
Select License Type
US : +1 (716) 218-3733
UK : +44 (208) 1235555
Select License Type
FATPOS CLIENT Appriciation DURING THE PROJECT